Market check Index Current Pt. Change % Change   S&P BSE SENSEX 33,804.87 +58.09 +0.17   S&P BSE SENSEX 50 10,850.65 +34.57 +0.32   S&P BSE SENSEX Next 50 33,468.63 +200.74 +0.60   S&P BSE 100 10,752.71 +38.94 +0.36   S&P BSE Bharat 22 Index 3,549.63 +5.00 +0.14 (Source: BSE) STOCK WATCH Top gainers (BSE 500 index) COMPANY LATEST PREV CLOSE GAIN() GAIN(%) VOLUME SCHNEIDER ELECT. 112.30 105.45 6.85 6.50 72023 PHOENIX MILLS 687.40 649.95 37.45 5.76 35905 BAJAJ HOLDINGS 2843.00 2705.45 137.55 5.08 4815 VAKRANGEE 170.65 162.55 8.10 4.98 673696 DILIP BUILDCON 1002.65 962.10 40.55 4.21 106943 Equinomics maintains buy rating on Bayer Cropscience   The company’s strong presence in key crops of fruits and vegetables, cotton, and rice, along with a growing product portfolio, provides us comfort on the long-term growth trajectory. We expect Bayer to outperform industry growth given its strong product portfolio and line-up of new launches over the next few years.   At the current market price the stock trades at 36.7x its FY2018E EPS of Rs.104 and at 32.6x its FY2019E EPS of Rs.117. We reiterate a BUY on the stock with a target price of Rs.5,000 (which is 42.7x its FY2019E EPS of Rs.117). This leading global player in the agri space mostly trades at substantial premium in the Indian equity markets and we believe that it would continue to enjoy such high premium in future as well SITI Networks hits over four-year low; stock falls 14% SITI Networks hit an over four-year low of Rs 15.70, down 14% on the BSE in intra-day trade, on back of heavy volumes. The stock is trading at its lowest level since September 2013. READ MORE Stock in News   Shares of Gitanjali Gems cracked another 5% in morning trade on bourses today after CBI said that the PNB fraud was going on since 2010. The CBI yesterday said the violation of norms for issuance of Letters of Undertaking (LoUs) to benefit billionaire jeweller Nirav Modi and his uncle Mehul Choksi had been going on since 2010. Reacting to the development, Gitanjali Gems stocvk slumped 5 per cent, to hit its fresh 52-week low of Rs 18.35 on BSE. Sharekhan on Grasim   Grasim is on a strong growth trajectory, with ongoing restructuring through trimming down its loss-making businesses (fertiliser and telecom) and expanding its profit-making divisions (viscose, chemical and cement). Better earningsgrowth would also significantly improve return ratios at a consolidated level and trigger re-rating of the stock.    Tactically, the inclusion of Grasim in Nifty 50 Index with effect from April 2, 2018, is also a re-rating trigger. We maintain our Buy recommendation with a revised price target of Rs. 1,480 (upward revision driven by lower share of Idea losses and strong demand in standalone VSF business).